Lv1
78 积分 2025-04-08 加入
[2019 Chinese Society of Cardiology (CSC) guidelines for the diagnosis and management of patients with ST-segment elevation myocardial infarction]
12天前
已完结
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
12天前
已完结
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
17天前
已完结
Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action
18天前
已完结
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
19天前
已完结
Impact of Body Mass Index, Central Adiposity, and Weight Loss on the Benefits of Tirzepatide in HFpEF
24天前
已完结
Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction
25天前
已完结
[Guidelines for the management of non-ST elevation acute coronary syndromes (2024)]
26天前
已完结
The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease
1个月前
已完结
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
1个月前
已完结
皖公网安备34019202002308
